Role of adiponectin in patients with end-stage renal failure
| Author | Sara Beigrezaei | en |
| Author | Maryam Heidari | en |
| Author | Mohammad Reza Tammaddon | en |
| Orcid | Mohammad Reza Tammaddon [0000-0002-8830-5890] | en |
| Issued Date | 2017-09-30 | en |
| Abstract | Adiponectin is a cytokine produced by the adipose tissue. This collagen-like protein has 244-amino acid and its concentration in plasma of healthy individuals is 5-40 μg / mL. In fact, adiponectin comprises 1% of the total serum protein. Although, adiponectin has anti-inflammatory and anti-atherogenic effects in physiological conditions and plays a key role in lipid and glucose metabolism and energy balance as well. However, in patients with end-stage renal disease, it is not a protector due to the changes in the structure and function, and also is considered as a risk factor. So with regard to the prevalence of atherosclerosis in patients with end stage renal disease, adiponectin may be a marker for indentifying the cardiovascular involvement of these patients. | en |
| DOI | https://doi.org/ | en |
| Keyword | Adiponectin | en |
| Keyword | Atherosclerosis | en |
| Keyword | Kidney Diseases | en |
| Keyword | Cardiovascular Diseases | en |
| Keyword | Adipose Tissue | en |
| Keyword | آدیپونکتین | en |
| Keyword | آترواسکلروز | en |
| Keyword | بیماریهای کلیوی | en |
| Keyword | بیماریهای قلبی عروقی | en |
| Keyword | بافت چربی | en |
| Publisher | Brieflands | en |
| Title | Role of adiponectin in patients with end-stage renal failure | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- article-1-3565-fa.pdf.pdf
- Size:
- 575.36 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF